Rosa González-Sastre

Ms. Rosa González-Sastre

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Tissue Engineering
Verified
Journal Article
Open access
RGRosa González-Sastre
Rosa González-Sastre
RCRaquel Coronel
Raquel Coronel
Adela Bernabeu ZornozaAdela Bernabeu Zornoza
Adela Bernabeu Zornoza
PMPatricia Mateos-Martínez
Patricia Mateos-Martínez
ARAndreea Rosca
Andreea Rosca
ILIsabel Liste
Isabel Liste
Human cerebral organoids (hCOs) offer the possibility of deepening the knowledge of human brain development, as well as the pathologies that affect it. The method developed here describes the efficient generation of hCOs by going directly from two-dimensional (2D) pluripotent stem cell (PSC) cultures to three-dimensional (3D) neuroepithelial tissue, avoiding dissociation and aggregation steps. This has been achieved by subjecting 2D cultures, from the beginning of the neural induction step, to dual-SMAD inhibition in combination with CHIR99021. This is a simple and reproducible protocol in which the hCOs generated develop properly presenting proliferative ventricular zones (VZs) formed by neural precursor and radial glia (RG) that differentiate to give rise to mature neurons and glial cells. The hCOs present additional cell types such as oligodendrocyte precursors, astrocytes, microglia-like cells, and endothelial-like cells. This new approach could help to overcome some of the existing limitations in the field of organoid biotechnology, facilitating its execution in any laboratory setting.

11 March 2025 in STAR Protocols
Verified
Journal Article
Open access
RGRosa González-Sastre
Rosa González-Sastre
RCRaquel Coronel
Raquel Coronel
PMPatricia Mateos-Martínez
Patricia Mateos-Martínez
LMLaura Maeso
Laura Maeso
ELElena Llorente-Beneyto
Elena Llorente-Beneyto
ILIsabel Liste
Isabel Liste
Human cerebral organoids (hCOs) provide an excellent model for the study of human brain development and disease. Here, we present a protocol to obtain hCOs directly from two-dimensional (2D) pluripotent stem cell (PSC) cultures, avoiding cell dissociation and posterior embryoid body (EB) aggregation. We describe steps for subjecting 2D cultures to a neural fate and subsequently developing hCOs. We then detail the evaluation of different cellular types. For complete details on the use and execution of this protocol, please refer to González-Sastre et al.1.

10 March 2026 in Organoids
Verified
Journal Article
Open access
PDF file
PMPatricia Mateos-Martínez
Patricia Mateos-Martínez
DPDeanira Patrone
Deanira Patrone
MFMilagros González Flores
Milagros González Flores
CSCristina Soriano-Amador
Cristina Soriano-Amador
RGRosa González-Sastre
Rosa González-Sastre
ILIsabel Liste
Isabel Liste
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia, for which there is currently no cure. The causes of AD are still not well understood, although 5% of cases are known to have a genetic origin, associated with pathogenic genetic variants of the APP and PSEN1/2 genes. There is growing evidence that both APP and PSEN1/2 are also essential for proper human brain development and neural/neuronal function. This implies that abnormalities in early brain development could increase neuronal vulnerability to AD later in life. Human cerebral organoids (hCOs), generated from induced pluripotent stem cells (iPSCs) from AD patients, provide an exceptional model for better understanding the cellular and molecular mechanisms involved in human brain development, as well as early neurological alterations in the evolution of AD. This review compiles the main studies in which hCOs are used as a model for studying AD and for the discovery of new biomarkers. We also discuss the advantages and applications of these hCOs for studying the early stages of AD from a neurodevelopmental perspective. Finally, we mention the main current challenges in the use of hCOs for future research into AD.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
RGRosa González-Sastre
Rosa González-Sastre
RCRaquel Coronel
Raquel Coronel
Adela Bernabeu ZornozaAdela Bernabeu Zornoza
Adela Bernabeu Zornoza
ARAndreea Rosca
Andreea Rosca
PMPatricia Mateos-Martínez
Patricia Mateos-Martínez
ILIsabel Liste
Isabel Liste

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
PMPatricia Mateos-Martínez
Patricia Mateos-Martínez
RGRosa González-Sastre
Rosa González-Sastre
RCRaquel Coronel
Raquel Coronel
ARAndreea Rosca
Andreea Rosca
LMLaura Maeso
Laura Maeso
ILIsabel Liste
Isabel Liste

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
RCRaquel Coronel
Raquel Coronel
ARAndreea Rosca
Andreea Rosca
RGRosa González-Sastre
Rosa González-Sastre
PMPatricia Mateos-Martínez
Patricia Mateos-Martínez
MGMarta Gallego
Marta Gallego
LVLopez-Alonso victoria
Lopez-Alonso victoria